[Lowe's syndrome in 2 sisters].

T. Klempous,W. Prusek,W. Zylka

1976-11-01

Pediatria Polska

Abstract:

What problem does this paper attempt to address?

Modification of Respiratory Drive and Lung Stress by Level of Support Pressure and ECMO Sweep Gas Flow in Patients With Severe COVID-19-Associated Acute Respiratory Distress Syndrome: an Exploratory Retrospective Analysis

Carolin Jung,Hans-Jörg Gillmann,Thomas Stueber

DOI: https://doi.org/10.1053/j.jvca.2023.09.040

Abstract:Objectives: Patients with severe acute respiratory distress syndrome (ARDS) often exhibit an unusually strong respiratory drive, which predisposes them to effort-induced lung injury. Careful titration of support pressure via the ventilator and carbon dioxide removal via extracorporeal membrane oxygenation (ECMO) may attenuate respiratory drive and lung stress. Design: A retrospective cohort study. Setting: At a single center, a university hospital. Participants: Ten patients with severe COVID-19-associated ARDS (CARDS) on venovenous ECMO therapy. Interventions: Assessment of the effect of titrated support pressure and titrated ECMO sweep gas flow on respiratory drive and lung stress in spontaneously breathing patients during ECMO therapy. Measurements and main results: Airway occlusion pressure (P0.1) and the total swing of the transpulmonary pressure were determined as surrogate parameters of respiratory drive and lung stress. Ventilator-mediated elevation of support pressure decreased P0.1 but increased transpulmonary driving pressure, airway pressure, tidal volume, and end-inspiratory transpulmonary occlusion pressure. The increase in ECMO sweep gas flow lowered P0.1, transpulmonary pressures, tidal volume, and respiratory frequency linearly. Conclusions: In patients with CARDS on pressure support ventilation, even moderate support pressure may lead to overassistance during assisted ventilation, which is only reflected by advanced monitoring of respiratory mechanics. Modifying carbon dioxide removal via the extracorporeal system profoundly affects respiratory effort and mechanics. Spontaneously breathing patients with CARDS may benefit from consequent carbon dioxide removal.
Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies

Domenico Luca Grieco,Filippo Bongiovanni,Lu Chen,Luca S. Menga,Salvatore Lucio Cutuli,Gabriele Pintaudi,Simone Carelli,Teresa Michi,Flava Torrini,Gianmarco Lombardi,Gian Marco Anzellotti,Gennaro De Pascale,Andrea Urbani,Maria Grazia Bocci,Eloisa S. Tanzarella,Giuseppe Bello,Antonio M. Dell’Anna,Salvatore M. Maggiore,Laurent Brochard,Massimo Antonelli

DOI: https://doi.org/10.1186/s13054-020-03253-2

IF: 15.1

2020-08-28

Critical Care

Abstract:Abstract Background Whether respiratory physiology of COVID-19-induced respiratory failure is different from acute respiratory distress syndrome (ARDS) of other etiologies is unclear. We conducted a single-center study to describe respiratory mechanics and response to positive end-expiratory pressure (PEEP) in COVID-19 ARDS and to compare COVID-19 patients to matched-control subjects with ARDS from other causes. Methods Thirty consecutive COVID-19 patients admitted to an intensive care unit in Rome, Italy, and fulfilling moderate-to-severe ARDS criteria were enrolled within 24 h from endotracheal intubation. Gas exchange, respiratory mechanics, and ventilatory ratio were measured at PEEP of 15 and 5 cmH 2 O. A single-breath derecruitment maneuver was performed to assess recruitability. After 1:1 matching based on PaO 2 /FiO 2 , FiO 2 , PEEP, and tidal volume, COVID-19 patients were compared to subjects affected by ARDS of other etiologies who underwent the same procedures in a previous study. Results Thirty COVID-19 patients were successfully matched with 30 ARDS from other etiologies. At low PEEP, median [25th–75th percentiles] PaO 2 /FiO 2 in the two groups was 119 mmHg [101–142] and 116 mmHg [87–154]. Average compliance (41 ml/cmH 2 O [32–52] vs. 36 ml/cmH 2 O [27–42], p = 0.045) and ventilatory ratio (2.1 [1.7–2.3] vs. 1.6 [1.4–2.1], p = 0.032) were slightly higher in COVID-19 patients. Inter-individual variability (ratio of standard deviation to mean) of compliance was 36% in COVID-19 patients and 31% in other ARDS. In COVID-19 patients, PaO 2 /FiO 2 was linearly correlated with respiratory system compliance ( r = 0.52 p = 0.003). High PEEP improved PaO 2 /FiO 2 in both cohorts, but more remarkably in COVID-19 patients ( p = 0.005). Recruitability was not different between cohorts ( p = 0.39) and was highly inter-individually variable (72% in COVID-19 patients and 64% in ARDS from other causes). In COVID-19 patients, recruitability was independent from oxygenation and respiratory mechanics changes due to PEEP. Conclusions Early after establishment of mechanical ventilation, COVID-19 patients follow ARDS physiology, with compliance reduction related to the degree of hypoxemia, and inter-individually variable respiratory mechanics and recruitability. Physiological differences between ARDS from COVID-19 and other causes appear small.

critical care medicine
Respiratory drive heterogeneity associated with systemic inflammation and vascular permeability in acute respiratory distress syndrome

Elias Baedorf-Kassis,Michael Murn,Amy L. Dzierba,Alexis L. Serra,Ivan Garcia,Emily Minus,Clarissa Padilla,Todd Sarge,Valerie M. Goodspeed,Michael A. Matthay,Michelle N. Gong,Deborah Cook,Stephen H. Loring,Daniel Talmor,Jeremy R. Beitler,Daniel Talmor,Todd Sarge,Valerie Goodspeed,Emily Fish,Sayuri Jinadasa,Ray Ritz,Joseph Previtera,Michelle N. Gong,Lawrence Lee,Jeremy R. Beitler,Deborah Cook,France Clarke,Tom Piraino,Joseph Levitt,Rosemary Vojnik,Pauline Park,Kristin Brierley,Carl Haas,Andrew Weirauch,Eddy Fan,Andrea Matte,R. Scott Harris,Mamary Kone,Stephen Heard,Karen Longtine,Franćois Lellouche,Pierre-Alexandre Bouchard,Lewis Rubinson,Jennifer McGrain,Donald E. G. Griesdale,Denise Foster,Richard Oeckler,Amy Amsbaugh,Edgar Jimenez,Valerie Danesh,for the EPVent-2 Study Group

DOI: https://doi.org/10.1186/s13054-024-04920-4

IF: 15.1

2024-04-25

Critical Care

Abstract:In acute respiratory distress syndrome (ARDS), respiratory drive often differs among patients with similar clinical characteristics. Readily observable factors like acid–base state, oxygenation, mechanics, and sedation depth do not fully explain drive heterogeneity. This study evaluated the relationship of systemic inflammation and vascular permeability markers with respiratory drive and clinical outcomes in ARDS.

critical care medicine
High vs Low PEEP in Patients With ARDS Exhibiting Intense Inspiratory Effort During Assisted Ventilation: A Randomized Crossover Trial

Giuseppe Bello,Valentina Giammatteo,Alessandra Bisanti,Luca Delle Cese,Tommaso Rosà,Luca S Menga,Luca Montini,Teresa Michi,Giorgia Spinazzola,Gennaro De Pascale,Mariano Alberto Pennisi,Roberta Ribeiro De Santis Santiago,Lorenzo Berra,Massimo Antonelli,Domenico Luca Grieco

DOI: https://doi.org/10.1016/j.chest.2024.01.040

IF: 9.6

Chest

Abstract:Background: Positive end-expiratory pressure (PEEP) can potentially modulate inspiratory effort (ΔPes), which is the major determinant of self-inflicted lung injury. Research question: Does high PEEP reduce ΔPes in patients with moderate-to-severe ARDS on assisted ventilation? Study design and methods: Sixteen patients with Pao2/Fio2 ≤ 200 mm Hg and ΔPes ≥ 10 cm H2O underwent a randomized sequence of four ventilator settings: PEEP = 5 cm H2O or PEEP = 15 cm H2O + synchronous (pressure support ventilation [PSV]) or asynchronous (pressure-controlled intermittent mandatory ventilation [PC-IMV]) inspiratory assistance. ΔPes and respiratory system, lung, and chest wall mechanics were assessed with esophageal manometry and occlusions. PEEP-induced alveolar recruitment and overinflation, lung dynamic strain, and tidal volume distribution were assessed with electrical impedance tomography. Results: ΔPes was not systematically different at high vs low PEEP (pressure support ventilation: median, 20 cm H2O; interquartile range (IQR), 15-24 cm H2O vs median, 15 cm H2O; IQR, 13-23 cm H2O; P = .24; pressure-controlled intermittent mandatory ventilation: median, 20; IQR, 18-23 vs median, 19; IQR, 17-25; P = .67, respectively). Similarly, respiratory system and transpulmonary driving pressures, tidal volume, lung/chest wall mechanics, and pendelluft extent were not different between study phases. High PEEP resulted in lower or higher ΔPes, respiratory system driving pressure, and transpulmonary driving pressure according to whether this increased or decreased respiratory system compliance (r = -0.85, P < .001; r = -0.75, P < .001; r = -0.80, P < .001, respectively). PEEP-induced changes in respiratory system compliance were driven by its lung component and were dependent on the extent of PEEP-induced alveolar overinflation (r = -0.66, P = .006). High PEEP caused variable recruitment and systematic redistribution of tidal volume toward dorsal lung regions, thereby reducing dynamic strain in ventral areas (pressure support ventilation: median, 0.49; IQR, 0.37-0.83 vs median, 0.96; IQR, 0.62-1.56; P = .003; pressure-controlled intermittent mandatory ventilation: median, 0.65; IQR, 0.42-1.31 vs median, 1.14; IQR, 0.79-1.52; P = .002). All results were consistent during synchronous and asynchronous inspiratory assistance. Interpretation: The impact of high PEEP on ΔPes and lung stress is interindividually variable according to different effects on the respiratory system and lung compliance resulting from alveolar overinflation. High PEEP may help mitigate the risk of self-inflicted lung injury solely if it increases lung/respiratory system compliance. Trial registration: ClinicalTrials.gov; No.: NCT04241874; URL: www. Clinicaltrials: gov.
Partition of respiratory mechanics in patients with acute respiratory distress syndrome and association with outcome: a multicentre clinical study

Lu Chen,Domenico L. Grieco,François Beloncle,Guang-Qiang Chen,Norberto Tiribelli,Fabiana Madotto,Sebastian Fredes,Cong Lu,Massimo Antonelli,Alain Mercat,Arthur S. Slutsky,Jian-Xin Zhou,Laurent Brochard,Chen, Lu,Grieco, Domenico L.,Beloncle, François,Chen, Guang-Qiang,Tiribelli, Norberto,Madotto, Fabiana,Fredes, Sebastian,Lu, Cong,Antonelli, Massimo,Mercat, Alain,Slutsky, Arthur S.,Zhou, Jian-Xin,Brochard, Laurent

DOI: https://doi.org/10.1007/s00134-022-06724-y

IF: 38.9

2022-06-07

Intensive Care Medicine

Abstract:In acute respiratory distress syndrome (ARDS), physiological parameters associated with outcome may help defining targets for mechanical ventilation. This study aimed to address whether transpulmonary pressures (PL), including transpulmonary driving pressure (DPL), elastance-derived plateau PL, and directly-measured end-expiratory PL, are better associated with 60-day outcome than airway driving pressure (DPaw). We also tested the combination of oxygenation and stretch index [PaO2/(FiO2*DPaw)]. Prospective, observational, multicentre registry of ARDS patients. Respiratory mechanics were measured early after intubation at 6 kg/ml tidal volume. We compared the predictive power of the parameters for mortality at day-60 through receiver operating characteristic (ROC) and assessed their association with 60-day mortality through unadjusted and adjusted Cox regressions. Finally, each parameter was dichotomized, and Kaplan–Meier survival curves were compared. 385 patients were enrolled 2 [1–4] days from intubation (esophageal pressure and arterial blood gases in 302 and 318 patients). As continuous variables, DPaw, DPL, and oxygenation stretch index were associated with 60-day mortality after adjustment for age and Sequential Organ Failure Assessment, whereas elastance-derived plateau PL was not. DPaw and DPL performed equally in ROC analysis (P = 0.0835). DPaw had the best-fit Cox regression model. When dichotomizing the variables, DPaw ≥ 15, DPL ≥ 12, plateau PL ≥ 24, and oxygenation stretch index < 10 exhibited lower 60-day survival probability. Directly measured end-expiratory PL ≥ 0 was associated with better outcome in obese patients. DPL was equivalent predictor of outcome than DPaw. Our study supports the soundness of limiting lung and airway driving pressure and maintaining positive end-expiratory PL in obese patients.

critical care medicine
Lung (extracorporeal CO2 removal) and renal (continuous renal replacement therapy) support: the role of ultraprotective strategy in Covid 19 and non-Covid 19 ARDS. A case-control study

Daniela Pasero,Laura Pistidda,Davide Piredda,Corrado Liperi,Andrea Cossu,Raffaella Esposito,Angela Muroni,Cristiano Mereu,Carlino Rum,Gian Pietro Branca,Franco Mulas,Mariangela Puci,Giovanni Sotgiu,Pierpaolo Terragni

DOI: https://doi.org/10.1186/s44158-024-00164-4

2024-04-27

Abstract:Background: Preliminary studies suggest that moderate ARDS and acute renal failure might benefit from extracorporeal CO2 removal (ECCO2R) coupled with CRRT. However, evidence is limited and potential for this coupled treatment may need to be explored. The aim of the present study was to evaluate whether a protective driving pressure was obtained applying low-flow ECCO2-R plus CRRT in patients affected by moderate ARDS with COVID-19 compared to an historical group without COVID-19. Methods: A case-control study has been conducted comparing a group of consecutive moderate ARDS patients presenting AKI and affected by COVID-19, who needed low-flow ECCO2-R plus CRRT to achieve an ultra-protective ventilatory strategy, with historical group without COVID-19 that matched for clinical presentation and underwent the same ultra-protective treatment. VT was set at 6 mL/kg predicted body weight then ECCO2R was assessed to facilitate ultra-protective low VT ventilation to preserve safe Pplat and low driving pressure. Results: ECCO2R+CRRT reduced the driving pressure from 17 (14-18) to 11.5 (10-15) cmH2O (p<0.0004) in the fourteen ARDS patients by decreasing VT from 6.7 ml/kg PBW (6.1-6.9) to 5.1 (4.2-5.6) after 1 hour (p <0.0001). In the ARDS patients with COVID-19, the driving pressure reduction was more effective from baseline 18 (14-24) cmH2O to 11 (10-15) cmH2O (p<0.004), compared to the control group from 15 (13-17) to 12(10-16) cmH2O (p< 0.03), after one hour. ECCO2R+CRRT did not affected 28 days mortality in the two groups, while we observed a shorter duration of mechanical ventilation (19 {7-29} vs 24 {22-38} days; p=0.24) and ICU length of stay (19 {7-29} vs 24 {22-78} days; p=0.25) in moderate ARDS patients with COVID-19 compared to control group. Conclusions: In moderate ARDS patients with or without COVID-19 disease, ECCO2R+CRRT may be and effective supportive treatment to reach protective values of driving pressure unless severe oxygenation defects arise requiring ECMO therapy initiation.
Different ventilation intensities among various categories of patients ventilated for reasons other than ARDS––A pooled analysis of 4 observational studies

Simon Corrado Serafini,David M.P. van Meenen,Luigi Pisani,Ary Serpa Neto,Lorenzo Ball,Marcelo Gama de Abreu,Anna Geke Algera,Luciano Azevedo,Giacomo Bellani,Arjen M. Dondorp,Eddy Fan,John G. Laffey,Tai Pham,Edda M. Tschernko,Marcus J. Schultz,Margaretha C.E. van der Woude

DOI: https://doi.org/10.1016/j.jcrc.2024.154531

IF: 4.298

2024-02-12

Journal of Critical Care

Abstract:Purpose We investigated driving pressure (ΔP) and mechanical power (MP) and associations with clinical outcomes in critically ill patients ventilated for reasons other than ARDS. Materials and methods Individual patient data analysis of a pooled database that included patients from four observational studies of ventilation. ΔP and MP were compared among invasively ventilated non–ARDS patients with sepsis, with pneumonia, and not having sepsis or pneumonia. The primary endpoint was ΔP; secondary endpoints included MP, ICU mortality and length of stay, and duration of ventilation. Results This analysis included 372 (11%) sepsis patients, 944 (28%) pneumonia patients, and 2040 (61%) patients ventilated for any other reason. On day 1, median ΔP was higher in sepsis (14 [ [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] ] cmH 2 O) and pneumonia patients (14 [ [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] ]cmH 2 O), as compared to patients not having sepsis or pneumonia (13 [ [10] , [11] , [12] , [13] , [14] , [15] , [16] ] cmH 2 O) ( P < 0.001). Median MP was also higher in sepsis and pneumonia patients. ΔP, as opposed to MP, was associated with ICU mortality in sepsis and pneumonia patients. Conclusions The intensity of ventilation differed between patients with sepsis or pneumonia and patients receiving ventilation for any other reason; ΔP was associated with higher mortality in sepsis and pneumonia patients. Registration This post hoc analysis was not registered; the individual studies that were merged into the used database were registered at clinicaltrials.gov : NCT01268410 (ERICC), NCT02010073 (LUNG SAFE), NCT01868321 (PRoVENT), and NCT03188770 (PRoVENT–iMiC).

critical care medicine
Recombinant thioredoxin peroxidase from Cryptosporidium parvum has more powerful antioxidant activity than that from Cryptosporidium muris.

S. Yoon,W. Park,Jae-Ran Yu

DOI: https://doi.org/10.1016/j.exppara.2012.04.018

IF: 2.132

2012-07-01

Experimental Parasitology

Abstract:
Inflammatory biomarkers and pendelluft magnitude in ards patients transitioning from controlled to partial support ventilation

Rodrigo A. Cornejo,Daniel H. Arellano,Pablo Ruiz-Rudolph,Dannette V. Guiñez,Caio C. A. Morais,Abraham I. J. Gajardo,Marioli T. Lazo,Roberto E. Brito,María A. Cerda,Sedric J. González,Verónica A. Rojas,Gonzalo A. Diaz,Lorena D. M. López,Juan N. Medel,Dagoberto I. Soto,Alejandro R. Bruhn,Marcelo B. P. Amato,Nivia R. Estuardo

DOI: https://doi.org/10.1038/s41598-022-24412-1

IF: 4.6

2022-11-25

Scientific Reports

Abstract:The transition from controlled to partial support ventilation is a challenge in acute respiratory distress syndrome (ARDS) patients due to the risks of patient-self-inflicted lung injury. The magnitude of tidal volume (V T ) and intrapulmonary dyssynchrony (pendelluft) are suggested mechanisms of lung injury. We conducted a prospective, observational, physiological study in a tertiary academic intensive care unit. ARDS patients transitioning from controlled to partial support ventilation were included. On these, we evaluated the association between changes in inflammatory biomarkers and esophageal pressure swing (ΔP es ), transpulmonary driving pressure (ΔP L ), V T , and pendelluft. Pendelluft was defined as the percentage of the tidal volume that moves from the non-dependent to the dependent lung region during inspiration, and its frequency at different thresholds (− 15, − 20 and − 25%) was also registered. Blood concentrations of inflammatory biomarkers (IL-6, IL-8, TNF-α, ANGPT2, RAGE, IL-18, Caspase-1) were measured before (T 0 ) and after 4-h (T 4 ) of partial support ventilation. Pendelluft, ΔP es , ΔP L and V T were recorded. Nine out of twenty-four patients (37.5%) showed a pendelluft mean ≥ 10%. The mean values of ΔP es , ΔP L , and V T were − 8.4 [− 6.7; − 10.2] cmH 2 O, 15.2 [12.3–16.5] cmH 2 O and 8.1 [7.3–8.9] m/kg PBW, respectively. Significant associations were observed between the frequency of high-magnitude pendelluft and IL-8, IL-18, and Caspase-1 changes (T 0 /T 4 ratio). These results suggest that the frequency of high magnitude pendelluft may be a potential determinant of inflammatory response related to inspiratory efforts in ARDS patients transitioning to partial support ventilation. Future studies are needed to confirm these results.

multidisciplinary sciences
Challenges in Transitioning from Controlled to Assisted Ventilation in Acute Respiratory Distress Syndrome (ARDS) Management

Denise Battaglini,Patricia R. M. Rocco

DOI: https://doi.org/10.3390/jcm13237333

IF: 3.9

2024-12-03

Journal of Clinical Medicine

Abstract:Acute respiratory distress syndrome (ARDS) presents significant challenges in critical care, primarily due to its inflammatory nature, which leads to impaired gas exchange and respiratory mechanics. While mechanical ventilation (MV) is essential for patient support, the transition from controlled to assisted ventilation is complex and may be associated with intensive care unit-acquired weakness, ventilator-induced diaphragmatic dysfunction and patient self-inflicted lung injury. This paper explores the multifaceted challenges encountered during this transition, with a focus on respiratory effort, sedation management, and monitoring techniques, and investigates innovative approaches to enhance patient outcomes. The key strategies include optimizing sedation protocols, employing advanced monitoring methods like esophageal pressure measurements, and implementing partial neuromuscular blockade to prevent excessive respiratory effort. We also emphasize the importance of personalized treatment plans and the integration of artificial intelligence to facilitate timely transitions. By highlighting early rehabilitation techniques, continuously assessing the respiratory drive, and fostering collaboration among multidisciplinary teams, clinicians can improve the transition from controlled to assisted MV, ultimately enhancing recovery and long-term respiratory health in patients with ARDS.

medicine, general & internal
Pressure Support Ventilation During Extracorporeal Membrane Oxygenation Support in Patients With Acute Respiratory Distress Syndrome

Benedetta Fumagalli,Marco Giani,Michela Bombino,Denise Fumagalli,Milena Merelli,Gaia Chiesa,Roberto Rona,Giacomo Bellani,Emanuele Rezoagli,Giuseppe Foti

DOI: https://doi.org/10.1097/MAT.0000000000002285

2024-08-09

Abstract:In the initial phases of veno-venous extracorporeal membrane oxygenation (VV ECMO) support for severe acute respiratory distress syndrome (ARDS), ultraprotective controlled mechanical ventilation (CMV) is typically employed to limit the progression of lung injury. As patients recover, transitioning to assisted mechanical ventilation can be considered to reduce the need for prolonged sedation and paralysis. This study aimed to evaluate the feasibility of transitioning to pressure support ventilation (PSV) during VV ECMO and to explore variations in respiratory mechanics and oxygenation parameters following the transition to PSV. This retrospective monocentric study included 191 adult ARDS patients treated with VV ECMO between 2009 and 2022. Within this population, 131 (69%) patients were successfully switched to PSV during ECMO. Pressure support ventilation was associated with an increase in respiratory system compliance (p = 0.02) and a reduction in pulmonary shunt fraction (p < 0.001). Additionally, improvements in the cardiovascular Sequential Organ Failure Assessment score and a reduction in pulmonary arterial pressures (p < 0.05) were recorded. Ninety-four percent of patients who successfully transitioned to PSV were weaned from ECMO, and 118 (90%) were discharged alive from the intensive care unit (ICU). Of those who did not reach PSV, 74% died on ECMO, whereas the remaining patients were successfully weaned from extracorporeal support. In conclusion, PSV is feasible during VV ECMO and potentially correlates with improvements in respiratory function and hemodynamics.
The Role of the Electrical Activity of the Diaphragm

Stefano Muttini,Jacopo Jona Falco,Ilmari Cuevas Cairo,Michele Umbrello

DOI: https://doi.org/10.3390/jcm13041120

IF: 3.9

2024-02-17

Journal of Clinical Medicine

Abstract:Background: Mechanical ventilation is the main supportive treatment of severe cases of COVID-19-associated ARDS (C-ARDS). Weaning failure is common and associated with worse outcomes. We investigated the role of respiratory drive, assessed by monitoring the electrical activity of the diaphragm (EAdi), as a predictor of weaning failure. Methods: Consecutive, mechanically ventilated patients admitted to the ICU for C-ARDS with difficult weaning were enrolled. Blood gas, ventilator, and respiratory mechanic parameters, as well as EAdi, were recorded at the time of placement of EAdi catheter, and then after 1, 2, 3, 7, and 10 days, and compared between patients with weaning success and weaning failure. Results: Twenty patients were enrolled: age 66 (60–69); 85% males; PaO2/FiO2 at admission 148 (126–177) mmHg. Thirteen subjects (65%) were classified as having a successful weaning. A younger age (OR(95%CI): 0.02 (0.01–0.11) per year), a higher PaO2/FiO2 ratio (OR(95%CI): 1.10 (1.01–1.21) per mmHg), and a lower EAdi (OR(95%CI): 0.16 (0.08–0.34) per μV) were associated with weaning success. Conclusion: In critically ill patients with moderate–severe C-ARDS and difficult weaning from mechanical ventilation, a successful weaning was associated with a lower age, a higher oxygenation, and a lower respiratory drive, as assessed at the bedside via EAdi monitoring.

medicine, general & internal
Impact of extended lung protection during mechanical ventilation on lung recovery in patients with COVID-19 ARDS: a phase II randomized controlled trial

Eduardo L. V. Costa,Glasiele C. Alcala,Mauro R. Tucci,Ewan Goligher,Caio C. Morais,Jose Dianti,Miyuki A. P. Nakamura,Larissa B. Oliveira,Sérgio M. Pereira,Carlos Toufen,Carmen S. V. Barbas,Carlos R. R. Carvalho,Marcelo B. P. Amato

DOI: https://doi.org/10.1186/s13613-024-01297-z

IF: 10.318

2024-06-10

Annals of Intensive Care

Abstract:Protective ventilation seems crucial during early Acute Respiratory Distress Syndrome (ARDS), but the optimal duration of lung protection remains undefined. High driving pressures (ΔP) and excessive patient ventilatory drive may hinder lung recovery, resulting in self-inflicted lung injury. The hidden nature of the ΔP generated by patient effort complicates the situation further. Our study aimed to assess the feasibility of an extended lung protection strategy that includes a stepwise protocol to control the patient ventilatory drive, assessing its impact on lung recovery.

critical care medicine
[Allergic conjunctivitis: diagnosis and treatment].

F. Marmouz,M. Raffard

European Annals of Allergy and Clinical Immunology

Abstract:Allergic conjunctivitis are the most frequent presentation of ocular allergy. They concern two specialists, ophthalmologists and allergists, who must establish a close collaboration, to succeed in an etiological diagnosis and consequent efficacious treatment. On one hand the history of allergy must be deep and on the other a simple pollen etiology giving simple functional signs: skin tests (pricks or epicutaneous) after a flawless questioning, at need completed by the measurement of specific and total IgE titres in the tears and even sometimes by a conjunctival provocation test, minimal other ophthalmological examination, researching anomalies in the tear level and signs of cellular suffering (Break-up time: time of rupture of the tear film). The differential diagnosis falls into the field of the ophthalmologist: traumatic or infectious conjunctivitis (herpes), vernal kerato-conjunctivitis for acute conjunctivitis; dry eye, viral conjunctivitis, anomalies of convergence for the most frequent signs of chronic conjunctivitis. The treatments are symptomatic to relieve the patient, eye lotions without preservatives for long term treatment and etiological that include allergen avoidance, without forgetting specific desensitisation (mites, pollens) that may need a rigorous indication.
Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?

Daniel H.L. Lemmers,Mohammed Abu Hilal,Claudio Bnà,Chiara Prezioso,Erika Cavallo,Niccolò Nencini,Serena Crisci,Federica Fusina,Giuseppe Natalini

DOI: https://doi.org/10.1183/23120541.00385-2020

IF: 4.239

2020-10-01

ERJ Open Research

Abstract:Background In mechanically ventilated acute respiratory distress syndrome (ARDS) patients infected with the novel coronavirus disease (COVID-19), we frequently recognised the development of pneumomediastinum and/or subcutaneous emphysema despite employing a protective mechanical ventilation strategy. The purpose of this study was to determine if the incidence of pneumomediastinum/subcutaneous emphysema in COVID-19 patients was higher than in ARDS patients without COVID-19 and if this difference could be attributed to barotrauma or to lung frailty. Methods We identified both a cohort of patients with ARDS and COVID-19 (CoV-ARDS), and a cohort of patients with ARDS from other causes (noCoV-ARDS). Patients with CoV-ARDS were admitted to an intensive care unit (ICU) during the COVID-19 pandemic and had microbiologically confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. NoCoV-ARDS was identified by an ARDS diagnosis in the 5 years before the COVID-19 pandemic period. Results Pneumomediastinum/subcutaneous emphysema occurred in 23 out of 169 (13.6%) patients with CoV-ARDS and in three out of 163 (1.9%) patients with noCoV-ARDS (p<0.001). Mortality was 56.5% in CoV-ARDS patients with pneumomediastinum/subcutaneous emphysema and 50% in patients without pneumomediastinum (p=0.46). CoV-ARDS patients had a high incidence of pneumomediastinum/subcutaneous emphysema despite the use of low tidal volume (5.9±0.8 mL·kg −1 ideal body weight) and low airway pressure (plateau pressure 23±4 cmH 2 O). Conclusions We observed a seven-fold increase in pneumomediastinum/subcutaneous emphysema in CoV-ARDS. An increased lung frailty in CoV-ARDS could explain this finding more than barotrauma, which, according to its etymology, refers to high transpulmonary pressure.
Airway Versus Transpulmonary Driving Pressures During Pressure Support Ventilation in ARDS

Christopher Z Zheng,Gustavo A Cortes-Puentes

DOI: https://doi.org/10.4187/respcare.11428

2023-10-21

Respiratory Care

Abstract:Like many other examples of habit changes over the decades of critical care medicine, lung-protective ventilation is constantly evolving toward less is more. Even though aggressive interventions are often justified in the initial stabilization phase, many aspects of mechanical ventilation management

respiratory system,critical care medicine
Static compliance of the respiratory system in COVID-19 related ARDS: an international multicenter study

Benoit Vandenbunder,Stephan Ehrmann,Michael Piagnerelli,Bertrand Sauneuf,Nicolas Serck,Thibaud Soumagne,Julien Textoris,Christophe Vinsonneau,Nadia Aissaoui,Gauthier Blonz,Giuseppe Carbutti,Romain Courcelle,Alain D’hondt,Stephane Gaudry,Julien Higny,Geoffroy Horlait,Sami Hraiech,Laurent Lefebvre,Francois Lejeune,Andre Ly,Jean-Baptiste Lascarrou,David Grimaldi,

DOI: https://doi.org/10.1186/s13054-020-03433-0

IF: 15.1

2021-02-08

Critical Care

Abstract:Abstract Background Controversies exist on the nature of COVID-19 related acute respiratory distress syndrome (ARDS) in particular on the static compliance of the respiratory system (Crs). We aimed to analyze the association of Crs with outcome in COVID-19-associated ARDS, to ascertain its determinants and to describe its evolution at day-14. Methods In this observational multicenter cohort of patients with moderate to severe Covid-19 ARDS, Crs was measured at day-1 and day-14. Association between Crs or Crs/ideal body weight (IBW) and breathing without assistance at day-28 was analyzed with multivariable logistic regression. Determinants were ascertained by multivariable linear regression. Day-14 Crs was compared to day-1 Crs with paired t-test in patients still under controlled mechanical ventilation. Results The mean Crs in 372 patients was 37.6 ± 13 mL/cmH 2 O, similar to as in ARDS of other causes. Multivariate linear regression identified chronic hypertension, low PaO 2 /FiO 2 ratio, low PEEP, and low tidal volume as associated with lower Crs/IBW. After adjustment on confounders, nor Crs [OR 1.0 (CI 95% 0.98–1.02)] neither Crs/IBW [OR 0.63 (CI 95% 0.13–3.1)] were associated with the chance of breathing without assistance at day-28 whereas plateau pressure was [OR 0.93 (CI 95% 0.88–0.99)]. In a subset of 108 patients, day-14 Crs decreased compared to day-1 Crs (31.2 ± 14.4 mL/cmH 2 O vs 37.8 ± 11.4 mL/cmH 2 O, p < 0.001). The decrease in Crs was not associated with day-28 outcome. Conclusion In a large multicenter cohort of moderate to severe COVID-19 ARDS, mean Crs was decreased below 40 mL/cmH 2 O and was not associated with day-28 outcome. Crs decreased between day-1 and day-14 but the decrease was not associated with day-28 outcome.

critical care medicine
Pressure control plus spontaneous ventilation versus volume assist-control ventilation in acute respiratory distress syndrome. A randomised clinical trial

Jean-Christophe M Richard,François M Beloncle,Gaëtan Béduneau,Satar Mortaza,Stephan Ehrmann,Jean-Luc Diehl,Gwenaël Prat,Samir Jaber,Hassene Rahmani,Jean Reignier,Thierry Boulain,Hodane Yonis,Jack Richecoeur,Arnaud W Thille,Pierre-Louis Declercq,Emmanuel Antok,Guillaume Carteaux,Bruno Vielle,Laurent Brochard,Alain Mercat,REVA network

DOI: https://doi.org/10.1007/s00134-024-07612-3

Abstract:Purpose: The aim of this study was to compare the effect of a pressure-controlled strategy allowing non-synchronised unassisted spontaneous ventilation (PC-SV) to a conventional volume assist-control strategy (ACV) on the outcome of patients with acute respiratory distress syndrome (ARDS). Methods: Open-label randomised clinical trial in 22 intensive care units (ICU) in France. Seven hundred adults with moderate or severe ARDS (PaO2/FiO2 < 200 mmHg) were enrolled from February 2013 to October 2018. Patients were randomly assigned to PC-SV (n = 348) or ACV (n = 352) with similar objectives of tidal volume (6 mL/kg predicted body weight) and positive end-expiratory pressure (PEEP). Paralysis was stopped after 24 h and sedation adapted to favour patients' spontaneous ventilation. The primary endpoint was in-hospital death from any cause at day 60. Results: Hospital mortality [34.6% vs 33.5%, p = 0.77, risk ratio (RR) = 1.03 (95% confidence interval [CI] 0.84-1.27)], 28-day mortality, as well as the number of ventilator-free days and organ failure-free days at day 28 did not differ between PC-SV and ACV groups. Patients in the PC-SV group received significantly less sedation and neuro-muscular blocking agents than in the ACV group. A lower proportion of patients required adjunctive therapy of hypoxemia (including prone positioning) in the PC-SV group than in the ACV group [33.1% vs 41.3%, p = 0.03, RR = 0.80 (95% CI 0.66-0.98)]. The incidences of pneumothorax and refractory hypoxemia did not differ between the groups. Conclusions: A strategy based on PC-SV mode that favours spontaneous ventilation reduced the need for sedation and adjunctive therapies of hypoxemia but did not significantly reduce mortality compared to ACV with similar tidal volume and PEEP levels.
Transpulmonary pressure measurements and lung mechanics in patients with early ARDS and SARS-CoV-2

Elias Baedorf Kassis,Maximilian S Schaefer,Jason H Maley,Ben Hoenig,Ying Loo,Margaret M Hayes,Ari Moskowitz,Daniel Talmor,Maximilian S. Schaefer,Jason H. Maley,Margaret M. Hayes

DOI: https://doi.org/10.1016/j.jcrc.2021.02.005

IF: 4.298

2021-06-01

Journal of Critical Care

Abstract:PurposeAcute Respiratory Distress Syndrome (ARDS) secondary to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has demonstrated variable oxygenation and respiratory-system mechanics without investigation of transpulmonary and chest-wall mechanics. This case series describes lung, chest wall and respiratory-system mechanics in patients with SARS-CoV-2 and ARDS.MethodsData was collected from forty patients with confirmed SARS-CoV-2 and ARDS at Beth Israel Deaconess Medical Center in Boston, Massachusetts. Esophageal balloons were placed to estimate pleural and transpulmonary pressures. Clinical characteristics, respiratory-system, transpulmonary, and chest-wall mechanics were measured over the first week.ResultsPatients had moderate-severe ARDS (PaO2/FiO2 123[98–149]) and were critically ill (APACHE IV 108 [94–128] and SOFA 12 [11–13]). PaO2/FiO2 improved over the first week (150 mmHg [122.9–182] to 185 mmHg [138–228] (p = 0.035)). Respiratory system (30–35 ml/cm H2O), lung (40–50 ml/cm H2O) and chest wall (120–150 ml/cm H2O) compliance remained similar over the first week. Elevated basal pleural pressures correlated with BMI. Patients required prolonged mechanical ventilation (14.5 days [9.5–19.0]), with a mortality of 32.5%.ConclusionsPatients displayed normal chest-wall mechanics, with increased basal pleural pressure. Respiratory system and lung mechanics were similar to known existing ARDS cohorts. The wide range of respiratory system mechanics illustrates the inherent heterogeneity that is consistent with typical ARDS.

critical care medicine
Comparing the impact of targeting limited driving pressure to low tidal volume ventilation on mortality in mechanically ventilated adults with COVID-19 ARDS: an exploratory target trial emulation

Maged Tanios,Ting Ting Wu,Huang Mark Nguyen,Louisa Smith,Raja Mahidhara,John W Devlin

DOI: https://doi.org/10.1136/bmjresp-2024-002439

2024-10-01

Abstract:Background: An association between driving pressure (∆P) and the outcomes of invasive mechanical ventilation (IMV) may exist. However, the effect of a sustained limitation of ∆P on mortality in patients with acute respiratory distress syndrome (ARDS), including patients with COVID-19 (COVID-19-related acute respiratory distress syndrome (C-ARDS)) undergoing IMV, has not been rigorously evaluated. The use of emulations of a target trial in intensive care unit research remains in its infancy. To inform future, large ARDS target trials, we explored using a target trial emulation approach to analyse data from a cohort of IMV adults with C-ARDS to determine whether maintaining daily ∆p<15 cm H2O (in addition to traditional low tidal volume ventilation (LTVV) (tidal volume 5-7 cc/PBW+plateau pressure (Pplat) ≤30 cm H2O), compared with LTVV alone, affects the 28-day mortality. Methods: To emulate a target trial, adults with C-ARDS requiring >24 hours of IMV were considered to be assigned to limited ∆P or LTVV. Lung mechanics were measured twice daily after ventilator setting adjustments were made. To evaluate the effect of each lung-protective ventilation (LPV) strategy on the 28-day mortality, we fit a stabilised inverse probability weighted marginal structural model that adjusted for baseline and time-varying confounders known to affect protection strategy use/adherence or survival. Results: Among the 92 patients included, 27 (29.3%) followed limited ∆P ventilation, 23 (25.0%) the LTVV strategy and 42 (45.7%) received no LPV strategy. The adjusted estimated 28-day survival was 47.0% (95% CI 23%, 76%) in the limited ∆P group, 70.3% in the LTVV group (95% CI 37.6%, 100%) and 37.6% (95% CI 20.8%, 58.0%) in the no LPV strategy group. Interpretation: Limiting ∆P may not provide additional survival benefits for patients with C-ARDS over LTVV. Our results help inform the development of future target trial emulations focused on evaluating LPV strategies, including reduced ∆P, in adults with ARDS.

[Lowe's syndrome in 2 sisters].

Modification of Respiratory Drive and Lung Stress by Level of Support Pressure and ECMO Sweep Gas Flow in Patients With Severe COVID-19-Associated Acute Respiratory Distress Syndrome: an Exploratory Retrospective Analysis

Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies

Respiratory drive heterogeneity associated with systemic inflammation and vascular permeability in acute respiratory distress syndrome

High vs Low PEEP in Patients With ARDS Exhibiting Intense Inspiratory Effort During Assisted Ventilation: A Randomized Crossover Trial

Partition of respiratory mechanics in patients with acute respiratory distress syndrome and association with outcome: a multicentre clinical study

Lung (extracorporeal CO2 removal) and renal (continuous renal replacement therapy) support: the role of ultraprotective strategy in Covid 19 and non-Covid 19 ARDS. A case-control study

Different ventilation intensities among various categories of patients ventilated for reasons other than ARDS––A pooled analysis of 4 observational studies

Recombinant thioredoxin peroxidase from Cryptosporidium parvum has more powerful antioxidant activity than that from Cryptosporidium muris.

Inflammatory biomarkers and pendelluft magnitude in ards patients transitioning from controlled to partial support ventilation

Challenges in Transitioning from Controlled to Assisted Ventilation in Acute Respiratory Distress Syndrome (ARDS) Management

Pressure Support Ventilation During Extracorporeal Membrane Oxygenation Support in Patients With Acute Respiratory Distress Syndrome

The Role of the Electrical Activity of the Diaphragm

Impact of extended lung protection during mechanical ventilation on lung recovery in patients with COVID-19 ARDS: a phase II randomized controlled trial

[Allergic conjunctivitis: diagnosis and treatment].

Pneumomediastinum and subcutaneous emphysema in COVID-19: barotrauma or lung frailty?

Airway Versus Transpulmonary Driving Pressures During Pressure Support Ventilation in ARDS

Static compliance of the respiratory system in COVID-19 related ARDS: an international multicenter study

Pressure control plus spontaneous ventilation versus volume assist-control ventilation in acute respiratory distress syndrome. A randomised clinical trial

Transpulmonary pressure measurements and lung mechanics in patients with early ARDS and SARS-CoV-2

Comparing the impact of targeting limited driving pressure to low tidal volume ventilation on mortality in mechanically ventilated adults with COVID-19 ARDS: an exploratory target trial emulation